BACKGROUND: Assisted partner services (APS) involves offering persons with human immunodeficiency virus (HIV) assistance notifying and testing their sex partners. Assisted partner services is rarely available in sub-Saharan Africa. We instituted a pilot APS program in Maputo, Mozambique. METHODS: Between June and September 2014, community health workers (CHWs) offered APS to persons with newly diagnosed HIV (index patients [IPs]). Community health workers interviewed IPs at baseline, 4 and 8 weeks. At baseline, CHWs counseled IPs to notify partners and encourage their HIV testing, but did not notify partners directly. At 4 weeks, CHWs notified partners directly. We compared 4- and 8-week outcomes to estimate the impact of APS on partner notification, HIV testing and HIV case finding. RESULTS: Community health workers offered 223 IPs APS, of whom 220 (99%) accepted; CHWs collected complete follow-up data on 206 persons; 79% were women, 74% were married, and 50% named >1 sex partner. Index patients named 262 HIV-negative partners at baseline. At 4 weeks, before APS, IPs had notified 193 partners (74%), but only 82 (31%) had HIV tested; 43 (13%) tested HIV positive. Assisted partner services resulted in the notification of 22 additional partners, testing of 83 partners and 43 new HIV diagnoses. In relative terms, APS increased partner notification, testing, and HIV case finding by 13%, 101%, and 125%. Seventy-two (35%) of 206 IPs were in ongoing HIV serodiscordant partnerships. Only 2.5 IPs needed to receive APS to identify a previously undiagnosed HIV-infected partner or an ongoing HIV serodiscordant partnership. Two (1%) IPs reported APS-related adverse events. CONCLUSIONS: Assisted partner services is acceptable to Mozambicans newly diagnosed with HIV, identifies large numbers of serodiscordant partnerships and persons with undiagnosed HIV, and poses a low risk of adverse events.
BACKGROUND: Assisted partner services (APS) involves offering persons with human immunodeficiency virus (HIV) assistance notifying and testing their sex partners. Assisted partner services is rarely available in sub-Saharan Africa. We instituted a pilot APS program in Maputo, Mozambique. METHODS: Between June and September 2014, community health workers (CHWs) offered APS to persons with newly diagnosed HIV (index patients [IPs]). Community health workers interviewed IPs at baseline, 4 and 8 weeks. At baseline, CHWs counseled IPs to notify partners and encourage their HIV testing, but did not notify partners directly. At 4 weeks, CHWs notified partners directly. We compared 4- and 8-week outcomes to estimate the impact of APS on partner notification, HIV testing and HIV case finding. RESULTS: Community health workers offered 223 IPsAPS, of whom 220 (99%) accepted; CHWs collected complete follow-up data on 206 persons; 79% were women, 74% were married, and 50% named >1 sex partner. Index patients named 262 HIV-negative partners at baseline. At 4 weeks, before APS, IPs had notified 193 partners (74%), but only 82 (31%) had HIV tested; 43 (13%) tested HIV positive. Assisted partner services resulted in the notification of 22 additional partners, testing of 83 partners and 43 new HIV diagnoses. In relative terms, APS increased partner notification, testing, and HIV case finding by 13%, 101%, and 125%. Seventy-two (35%) of 206 IPs were in ongoing HIV serodiscordant partnerships. Only 2.5 IPs needed to receive APS to identify a previously undiagnosed HIV-infected partner or an ongoing HIV serodiscordant partnership. Two (1%) IPs reported APS-related adverse events. CONCLUSIONS: Assisted partner services is acceptable to Mozambicans newly diagnosed with HIV, identifies large numbers of serodiscordant partnerships and persons with undiagnosed HIV, and poses a low risk of adverse events.
Authors: Marielle S Goyette; Peter M Mutiti; David Bukusi; Beatrice M Wamuti; Felix A Otieno; Peter Cherutich; Matthew R Golden; Hans Spiegel; Barbra A Richardson; Anne Ngʼangʼa; Carey Farquhar Journal: J Acquir Immune Defic Syndr Date: 2018-05-01 Impact factor: 3.731
Authors: Teralynn Ludwick; Alison Morgan; Sumit Kane; Margaret Kelaher; Barbara McPake Journal: Health Policy Plan Date: 2020-10-01 Impact factor: 3.344
Authors: Marie-Huguette K A Kingbo; Petros Isaakidis; Arielle Lasry; Kudakwashe C Takarinda; Marcel Manzi; John Pringle; Flore A Konan; Jules N'Draman; Nathalie Krou Danho; Armand K Abokon; Nicole Isabelle L Doumatey Journal: Sex Transm Dis Date: 2020-05-20 Impact factor: 2.830
Authors: Monisha Sharma; Jennifer A Smith; Carey Farquhar; Roger Ying; Peter Cherutich; Matthew Golden; Beatrice Wamuti; David Bukusi; Hans Spiegel; Ruanne V Barnabas Journal: AIDS Date: 2018-01-14 Impact factor: 4.177
Authors: Edward Kariithi; Monisha Sharma; Emily Kemunto; Harison Lagat; George Otieno; Beatrice M Wamuti; David A Katz; Christopher Obong'o; Paul Macharia; Rose Bosire; Sarah Masyuko; Mary Mugambi; Carol E Levin; Wenjia Liu; Unmesha Roy Paladhi; Bryan J Weiner; Carey Farquhar Journal: JMIR Res Protoc Date: 2021-05-20
Authors: Carey Farquhar; Bryan J Weiner; Wenjia Liu; Beatrice M Wamuti; Mercy Owuor; Harison Lagat; Edward Kariithi; Christopher Obong'o; Mary Mugambi; Monisha Sharma; Rose Bosire; Sarah Masyuko; David A Katz Journal: BMC Health Serv Res Date: 2022-05-07 Impact factor: 2.908
Authors: Marya Plotkin; Catherine Kahabuka; Alice Christensen; Denice Ochola; Myra Betron; Mustafa Njozi; Werner Maokola; Renatus Kisendy; Erick Mlanga; Kelly Curran; Mary Drake; Eusebi Kessy; Vincent Wong Journal: AIDS Behav Date: 2018-01
Authors: Katherine R Simon; Robert J Flick; Maria H Kim; Rachael A Sabelli; Tapiwa Tembo; Benjamin Ryan Phelps; Nora E Rosenberg; Saeed Ahmed Journal: J Acquir Immune Defic Syndr Date: 2018-08-15 Impact factor: 3.771